Filing Details

Accession Number:
0001209191-21-055494
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-10 17:17:18
Reporting Period:
2021-08-02
Accepted Time:
2021-09-10 17:17:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-02 15 $3.34 13,058 No 4 P Direct
Common Stock Acquisiton 2021-08-03 15 $3.17 13,073 No 4 P Direct
Common Stock Acquisiton 2021-08-04 15 $3.18 13,088 No 4 P Direct
Common Stock Acquisiton 2021-08-05 15 $3.11 13,103 No 4 P Direct
Common Stock Acquisiton 2021-08-06 15 $3.01 13,118 No 4 P Direct
Common Stock Acquisiton 2021-08-09 15 $2.93 13,133 No 4 P Direct
Common Stock Acquisiton 2021-08-10 15 $2.96 13,148 No 4 P Direct
Common Stock Acquisiton 2021-08-11 15 $2.98 13,163 No 4 P Direct
Common Stock Acquisiton 2021-08-13 15 $2.92 13,178 No 4 P Direct
Common Stock Acquisiton 2021-08-16 15 $2.92 13,193 No 4 P Direct
Common Stock Acquisiton 2021-08-17 15 $3.05 13,208 No 4 P Direct
Common Stock Acquisiton 2021-08-18 15 $2.97 13,223 No 4 P Direct
Common Stock Acquisiton 2021-08-19 15 $3.02 13,238 No 4 P Direct
Common Stock Acquisiton 2021-08-20 15 $2.96 13,253 No 4 P Direct
Common Stock Acquisiton 2021-08-23 15 $2.87 13,268 No 4 P Direct
Common Stock Acquisiton 2021-08-24 15 $2.89 13,283 No 4 P Direct
Common Stock Acquisiton 2021-08-25 15 $2.79 13,298 No 4 P Direct
Common Stock Acquisiton 2021-08-26 15 $2.82 13,313 No 4 P Direct
Common Stock Acquisiton 2021-08-27 15 $2.84 13,328 No 4 P Direct
Common Stock Acquisiton 2021-08-30 15 $2.88 13,343 No 4 P Direct
Common Stock Acquisiton 2021-08-31 15 $2.93 13,358 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.